Human C1 Esterase Inhibitor [EPC]

Human C1 Esterase Inhibitor [EPC] was reported 3893 times

Drugs of the Human C1 Esterase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 HEREDITARY ANGIOEDEMA 1798 0.1674
1 ALLERGY TO STING 2 0.1667
2 LARYNGEAL DYSKINESIA 20 0.1550
3 LARYNGEAL STENOSIS 52 0.0900
4 VOCAL CORD DYSFUNCTION 32 0.0649
5 HYPOCHOLESTEROLAEMIA 21 0.0595
6 PARAVENOUS DRUG ADMINISTRATION 2 0.0465
7 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME 2 0.0339
8 FLAGELLATE DERMATITIS 2 0.0308
9 VASCULAR ACCESS SITE COMPLICATION 7 0.0278
10 GENITOURINARY TRACT NEOPLASM 2 0.0241
11 LOCALISED OEDEMA 96 0.0207
12 PRESCRIBED OVERDOSE 400 0.0207
13 BLOOD IMMUNOGLOBULIN E INCREASED 50 0.0206
14 C-REACTIVE PROTEIN 18 0.0194
15 ALLERGY TO VACCINE 6 0.0194
16 TRACHEOSTOMY MALFUNCTION 4 0.0193
17 STATUS MIGRAINOSUS 3 0.0186
18 CATHETER THROMBOSIS 2 0.0179
19 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 9 0.0160
20 FACET JOINT SYNDROME 51 0.0156
21 CATHETER SITE VESICLES 3 0.0154
22 CENTRAL VENOUS CATHETER REMOVAL 7 0.0149
23 LARYNGEAL OEDEMA 92 0.0149
24 RESPIRATORY TRACT OEDEMA 11 0.0148
25 THERAPY REGIMEN CHANGED 6 0.0147
26 CHRONIC SINUSITIS 52 0.0138
27 HEPATIC ENZYME 2 0.0134
28 INFECTIVE GLOSSITIS 2 0.0128
29 PHARYNGEAL OEDEMA 192 0.0125
30 BLOOD IMMUNOGLOBULIN E DECREASED 2 0.0124
31 SWOLLEN JOINT COUNT 3 0.0120
32 SYNOVIAL RUPTURE 4 0.0116
33 DUMPING SYNDROME 3 0.0114
34 POOR VENOUS ACCESS 113 0.0109
35 NEUROSURGERY 2 0.0108
36 AXILLARY VEIN THROMBOSIS 4 0.0108
37 COMPLEMENT FACTOR C4 DECREASED 2 0.0104
38 OVERLAP SYNDROME 7 0.0100
39 DEEP VEIN THROMBOSIS POSTOPERATIVE 20 0.0100
40 GASTRODUODENITIS 2 0.0098
41 SPLENIC CYST 2 0.0096
42 MIXED CONNECTIVE TISSUE DISEASE 4 0.0095
43 LIP INFECTION 2 0.0094
44 RETINITIS 16 0.0093
45 PERIPHERAL VENOUS DISEASE 37 0.0091
46 DISLOCATION OF VERTEBRA 20 0.0088
47 LUPUS VULGARIS 11 0.0087
48 ORAL PUSTULE 2 0.0086
49 PORPHYRIA ACUTE 12 0.0084
50 COMPLEMENT FACTOR C3 DECREASED 2 0.0082
51 INCISION SITE DISCHARGE 2 0.0079
52 INGUINAL MASS 2 0.0078
53 MITE ALLERGY 5 0.0076
54 NEUROGENIC SHOCK 4 0.0074
55 CATHETER SITE THROMBOSIS 2 0.0073
56 X-RAY ABNORMAL 13 0.0073
57 DAIRY INTOLERANCE 2 0.0071
58 BREAST CANCER STAGE III 46 0.0071
59 OESOPHAGEAL OEDEMA 2 0.0071
60 SERONEGATIVE ARTHRITIS 8 0.0070
61 JUGULAR VEIN THROMBOSIS 12 0.0067
62 TRACHEITIS 5 0.0066
63 DUODENAL ULCER PERFORATION 48 0.0064
64 BLEPHAROSPASM 40 0.0063
65 INFUSION SITE HAEMATOMA 3 0.0063
66 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 13 0.0063
67 ALLERGY TO ARTHROPOD BITE 2 0.0063
68 BODY HEIGHT INCREASED 3 0.0061
69 ADMINISTRATION SITE PAIN 7 0.0061
70 INFUSION SITE REACTION 18 0.0060
71 ACUTE STRESS DISORDER 2 0.0060
72 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 4 0.0060
73 SWOLLEN JOINT COUNT INCREASED 19 0.0060
74 DETOXIFICATION 2 0.0058
75 DEVICE RELATED INFECTION 86 0.0056
76 LARYNGEAL DISORDER 4 0.0055
77 BLISTER RUPTURE 4 0.0054
78 THERAPY CHANGE 53 0.0054
79 OBSTRUCTIVE AIRWAYS DISORDER 59 0.0053
80 SUBCLAVIAN VEIN THROMBOSIS 6 0.0053
81 RHEUMATIC FEVER 23 0.0052
82 HEPATITIS C VIRUS TEST POSITIVE 3 0.0051
83 DEVICE RELATED THROMBOSIS 5 0.0051
84 CATHETER SITE EXTRAVASATION 2 0.0050
85 DEVICE RELATED SEPSIS 10 0.0050
86 MUSCLE INJURY 41 0.0049
87 INCISION SITE COMPLICATION 4 0.0048
88 MONOCLONAL GAMMOPATHY 3 0.0048
89 ONYCHOMADESIS 20 0.0048
90 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 34 0.0047
91 ALLERGY TO ANIMAL 5 0.0047
92 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 334 0.0047
93 NAIL DISORDER 41 0.0047
94 HELICOBACTER INFECTION 48 0.0047
95 INSURANCE ISSUE 70 0.0046
96 REFLUX LARYNGITIS 2 0.0045
97 LIP DRY 41 0.0045
98 WOUND INFECTION 49 0.0045
99 PRODUCT RECONSTITUTION QUALITY ISSUE 4 0.0045
100 BIOPSY BONE MARROW ABNORMAL 2 0.0044
101 ALLERGY TO PLANTS 2 0.0044
102 CATHETER SITE SWELLING 4 0.0043
103 VASCULAR DEVICE INFECTION 19 0.0042
104 LIVE BIRTH 35 0.0042
105 VEIN COLLAPSE 3 0.0039
106 BURSITIS 47 0.0039
107 CATHETER SITE PAIN 10 0.0039
108 BREAST FEEDING 3 0.0038
109 PHARYNGEAL PARAESTHESIA 6 0.0038
110 FOLLICULITIS 39 0.0037
111 HAEMATOLOGICAL INFECTION 9 0.0037
112 PANCREATITIS RELAPSING 3 0.0037
113 CENTRAL VENOUS CATHETERISATION 11 0.0036
114 HYPERTENSIVE URGENCY 2 0.0036
115 LOCAL SWELLING 63 0.0036
116 COVID-19 IMMUNISATION 3 0.0036
117 PEMPHIGUS 42 0.0034
118 INFUSION SITE HAEMORRHAGE 11 0.0033
119 INCORRECT DRUG ADMINISTRATION RATE 14 0.0033
120 PROLONGED LABOUR 2 0.0033
121 SINUS DISORDER 64 0.0032
122 JOINT DESTRUCTION 5 0.0032
123 VENOUS INJURY 3 0.0032
124 HAND DEFORMITY 42 0.0032
125 CATHETER SITE INFECTION 12 0.0032
126 PHARYNGEAL SWELLING 31 0.0032
127 VASCULAR PAIN 3 0.0031
128 BONE EROSION 11 0.0031
129 ANIMAL BITE 8 0.0030
130 EOSINOPHILIA 52 0.0030
131 PREGNANCY 59 0.0029
132 PRODUCT DISTRIBUTION ISSUE 27 0.0029
133 DRUG TOLERANCE DECREASED 8 0.0028
134 INFUSION SITE INFLAMMATION 2 0.0028
135 FACIAL DISCOMFORT 2 0.0028
136 PERICARDITIS 47 0.0028
137 MIDDLE INSOMNIA 52 0.0028
138 SPONDYLITIS 10 0.0027
139 HYPERCHOLESTEROLAEMIA 26 0.0027
140 STRESS AT WORK 3 0.0027
141 GASTROINTESTINAL BACTERIAL INFECTION 3 0.0026
142 ANGIOEDEMA 116 0.0026
143 JOINT RANGE OF MOTION DECREASED 35 0.0026
144 VEIN DISORDER 13 0.0026
145 RHEUMATOID FACTOR POSITIVE 15 0.0026
146 DRUG TOLERANCE INCREASED 2 0.0026
147 STOMACH MASS 2 0.0025
148 INFECTED CYST 3 0.0025
149 ABDOMINAL SYMPTOM 2 0.0025
150 INFUSION SITE OEDEMA 2 0.0024
151 VEIN RUPTURE 4 0.0024
152 MYOCARDIAL FIBROSIS 2 0.0024
153 TYMPANIC MEMBRANE PERFORATION 4 0.0024
154 OVARIAN CYST RUPTURED 3 0.0023
155 NODAL ARRHYTHMIA 2 0.0023
156 OBESITY 37 0.0023
157 INFUSION SITE BRUISING 5 0.0023
158 ABDOMINAL NEOPLASM 2 0.0022
159 FIBROMYALGIA 53 0.0022
160 DRUG TOLERANCE 11 0.0022
161 BIOPSY 2 0.0022
162 PHARYNGEAL HYPOAESTHESIA 2 0.0022
163 THERAPEUTIC PROCEDURE 3 0.0021
164 MAST CELL ACTIVATION SYNDROME 3 0.0021
165 SUSPECTED COVID-19 7 0.0021
166 INJECTION SITE SCAB 2 0.0021
167 ANIMAL SCRATCH 2 0.0021
168 AUTOIMMUNE DISORDER 20 0.0020
169 SPINAL LAMINECTOMY 2 0.0020
170 SWOLLEN TONGUE 63 0.0020
171 MESENTERIC VEIN THROMBOSIS 2 0.0020
172 INFUSION RELATED REACTION 133 0.0020
173 SKIN LESION 54 0.0020
174 RUBBER SENSITIVITY 3 0.0020
175 INFUSION SITE DISCOMFORT 2 0.0019
176 PRODUCT AVAILABILITY ISSUE 43 0.0019
177 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 31 0.0018
178 CATHETER SITE DISCHARGE 2 0.0018
179 PERIARTHRITIS 4 0.0018
180 LIVER INJURY 43 0.0018
181 BACK INJURY 19 0.0017
182 PELVIC ABSCESS 2 0.0017
183 GLOSSODYNIA 39 0.0017
184 SYNOVITIS 31 0.0017
185 PRURITUS ALLERGIC 2 0.0017
186 GASTROINTESTINAL OEDEMA 3 0.0017
187 IRRITABLE BOWEL SYNDROME 36 0.0017
188 PRODUCT PREPARATION ISSUE 11 0.0017
189 TASTE DISORDER 34 0.0017
190 WHEEZING 99 0.0017
191 EXOSTOSIS 15 0.0016
192 HORMONE LEVEL ABNORMAL 8 0.0016
193 INFUSION SITE WARMTH 2 0.0016
194 MEDICAL DEVICE COMPLICATION 12 0.0016
195 DENTAL CARE 3 0.0016
196 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 2 0.0016
197 GRIP STRENGTH DECREASED 14 0.0016
198 FOREIGN BODY IN THROAT 5 0.0016
199 EPILEPSY 48 0.0016
200 LIP HAEMORRHAGE 2 0.0016
201 BREAST CANCER STAGE II 13 0.0016
202 FOOD ALLERGY 12 0.0016
203 SYSTEMIC LUPUS ERYTHEMATOSUS 55 0.0015
204 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 10 0.0015
205 LIP INJURY 2 0.0015
206 DIPLEGIA 3 0.0015
207 LOWER LIMB FRACTURE 29 0.0015
208 TYPE 2 DIABETES MELLITUS 50 0.0015
209 ULCER HAEMORRHAGE 10 0.0015
210 INFUSION SITE RASH 2 0.0015
211 PUSTULAR PSORIASIS 5 0.0015
212 RHONCHI 2 0.0014
213 SCIATICA 23 0.0014
214 LUPUS-LIKE SYNDROME 13 0.0014
215 RENAL NEOPLASM 3 0.0014
216 SEASONAL ALLERGY 20 0.0014
217 SWELLING 132 0.0014
218 MULTIPLE ALLERGIES 11 0.0014
219 C-REACTIVE PROTEIN ABNORMAL 9 0.0014
220 CATHETER SITE ERYTHEMA 3 0.0014
221 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 2 0.0014
222 PHARYNGEAL DISORDER 4 0.0014
223 WALKING AID USER 9 0.0014
224 WOUND 38 0.0014
225 RED BLOOD CELL SEDIMENTATION RATE INCREASED 15 0.0014
226 COMPLEX REGIONAL PAIN SYNDROME 2 0.0014
227 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 65 0.0014
228 ARTHROPOD BITE 10 0.0013
229 WEIGHT FLUCTUATION 14 0.0013
230 BLOOD CULTURE POSITIVE 4 0.0013
231 JOINT DISLOCATION 14 0.0013
232 EXPOSURE DURING PREGNANCY 82 0.0013
233 INFUSION SITE PAIN 17 0.0013
234 AGE-RELATED MACULAR DEGENERATION 2 0.0013
235 DYSPHONIA 77 0.0013
236 INJECTION SITE PARAESTHESIA 2 0.0013
237 DISCOURAGEMENT 3 0.0013
238 CHOKING SENSATION 7 0.0013
239 ILL-DEFINED DISORDER 77 0.0013
240 FEAR OF INJECTION 9 0.0013
241 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 9 0.0013
242 CYSTITIS INTERSTITIAL 2 0.0012
243 RASH VESICULAR 6 0.0012
244 COMPLICATION ASSOCIATED WITH DEVICE 18 0.0012
245 MATERNAL EXPOSURE DURING BREAST FEEDING 5 0.0012
246 DERMATITIS CONTACT 14 0.0012
247 DERMAL CYST 3 0.0012
248 PANCREATIC DISORDER 6 0.0012
249 INTESTINAL POLYP 2 0.0012
250 SPINAL CORD DISORDER 2 0.0012
251 MATERNAL EXPOSURE DURING PREGNANCY 108 0.0012
252 PHARYNGITIS STREPTOCOCCAL 13 0.0012
253 SPLEEN DISORDER 2 0.0012
254 SEIZURE LIKE PHENOMENA 2 0.0012
255 SWELLING FACE 76 0.0012
256 LOWER RESPIRATORY TRACT INFECTION 53 0.0012
257 CONCUSSION 9 0.0012
258 IMPAIRED HEALING 38 0.0012
259 COMPARTMENT SYNDROME 3 0.0011
260 PSEUDOMONAL SEPSIS 2 0.0011
261 THROMBOPHLEBITIS 4 0.0011
262 PRODUCT USE ISSUE 214 0.0011
263 BREAST CYST 2 0.0011
264 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
265 PROTEIN TOTAL INCREASED 3 0.0011
266 PSORIATIC ARTHROPATHY 45 0.0011
267 NORMAL NEWBORN 6 0.0011
268 SKIN LACERATION 12 0.0011
269 THERAPEUTIC PRODUCT EFFECT DELAYED 5 0.0011
270 ABDOMINAL HERNIA 5 0.0011
271 CONDUCTION DISORDER 2 0.0011
272 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
273 FOOT DEFORMITY 12 0.0011
274 CHOLECYSTITIS INFECTIVE 3 0.0011
275 HEART RATE ABNORMAL 6 0.0011
276 C-REACTIVE PROTEIN INCREASED 39 0.0011
277 INFUSION SITE ERYTHEMA 9 0.0011
278 MATERNAL EXPOSURE TIMING UNSPECIFIED 4 0.0011
279 IMPATIENCE 2 0.0011
280 OSTEOARTHRITIS 45 0.0011
281 CONTRAINDICATED PRODUCT ADMINISTERED 32 0.0011
282 MECHANICAL VENTILATION 2 0.0011
283 PROCEDURAL COMPLICATION 8 0.0010
284 PRODUCT LABEL CONFUSION 6 0.0010
285 NASAL SEPTUM DEVIATION 2 0.0010
286 STRIDOR 3 0.0010
287 STAPHYLOCOCCAL SEPSIS 5 0.0010
288 HEPATIC CIRRHOSIS 19 0.0010
289 ANEURYSM 5 0.0010
290 PRESCRIBED UNDERDOSE 20 0.0010
291 NIGHT SWEATS 32 0.0010
292 EYE INJURY 3 0.0010
293 THERMAL BURN 7 0.0010
294 TOOTH ABSCESS 10 0.0010
295 LIVER FUNCTION TEST INCREASED 21 0.0010
296 EAR PAIN 19 0.0010
297 EAR INFECTION 26 0.0010
298 INFUSION SITE SWELLING 6 0.0010
299 PSYCHIATRIC SYMPTOM 7 0.0009
300 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 168 0.0009
301 INJECTION SITE INFECTION 3 0.0009
302 INFLAMMATION 47 0.0009
303 ROAD TRAFFIC ACCIDENT 38 0.0009
304 COLONOSCOPY 2 0.0009
305 CONGENITAL ANOMALY 7 0.0009
306 BREAST MASS 6 0.0009
307 INFECTIOUS MONONUCLEOSIS 2 0.0009
308 PULMONARY FIBROSIS 17 0.0009
309 OROPHARYNGEAL DISCOMFORT 8 0.0009
310 DRUG EFFECT DELAYED 4 0.0009
311 ARTHROPATHY 49 0.0009
312 CHEST DISCOMFORT 90 0.0009
313 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
314 CERVICAL VERTEBRAL FRACTURE 3 0.0009
315 NECK SURGERY 2 0.0009
316 EMBOLIC STROKE 3 0.0009
317 SKIN ABRASION 4 0.0008
318 FIBRIN D DIMER INCREASED 3 0.0008
319 PUSTULE 2 0.0008
320 PRODUCT SUPPLY ISSUE 6 0.0008
321 FINGER DEFORMITY 4 0.0008
322 FOETAL GROWTH RESTRICTION 5 0.0008
323 MUSCULOSKELETAL PAIN 43 0.0008
324 SINUSITIS 84 0.0008
325 LUNG DISORDER 40 0.0008
326 DENTAL OPERATION 2 0.0008
327 BACTERIAL INFECTION 15 0.0008
328 EPSTEIN-BARR VIRUS INFECTION 5 0.0008
329 CATHETER SITE HAEMORRHAGE 2 0.0008
330 SLEEP DISORDER 56 0.0008
331 GASTROINTESTINAL INFECTION 7 0.0008
332 MYOSITIS 7 0.0008
333 ENDOCARDITIS 4 0.0008
334 MENOPAUSE 2 0.0008
335 LIMB INJURY 21 0.0008
336 BLOOD CHOLESTEROL INCREASED 36 0.0008
337 HERNIA REPAIR 2 0.0008
338 ADVERSE DRUG REACTION 69 0.0008
339 TREATMENT NONCOMPLIANCE 42 0.0008
340 MIGRAINE 73 0.0008
341 INJECTION SITE DISCOMFORT 8 0.0008
342 POLYARTHRITIS 4 0.0008
343 ADVERSE REACTION 10 0.0008
344 NASAL DISORDER 2 0.0008
345 GAIT INABILITY 25 0.0007
346 BLISTER 42 0.0007
347 ABDOMINAL MASS 2 0.0007
348 ANAESTHETIC COMPLICATION 2 0.0007
349 SHOULDER ARTHROPLASTY 2 0.0007
350 HIP SURGERY 4 0.0007
351 LARGE INTESTINAL ULCER 2 0.0007
352 LIP BLISTER 2 0.0007
353 ABDOMINAL DISTENSION 76 0.0007
354 PHARYNGITIS 9 0.0007
355 ASTHMA 82 0.0007
356 UPPER RESPIRATORY TRACT INFECTION 33 0.0007
357 COELIAC DISEASE 7 0.0007
358 ENDOTRACHEAL INTUBATION 2 0.0007
359 OXYGEN SATURATION ABNORMAL 2 0.0007
360 RESPIRATORY SYMPTOM 2 0.0007
361 UPPER LIMB FRACTURE 14 0.0007
362 HEPATIC PAIN 3 0.0007
363 RESPIRATORY DISORDER 21 0.0007
364 THROMBOSIS 56 0.0007
365 PERIPHERAL SWELLING 107 0.0007
366 MONOPLEGIA 3 0.0007
367 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
368 HEPATIC ENZYME INCREASED 47 0.0007
369 BILIARY COLIC 2 0.0007
370 PULMONARY PAIN 2 0.0007
371 ONYCHOMYCOSIS 3 0.0007
372 LIGAMENT RUPTURE 3 0.0007
373 COVID-19 PNEUMONIA 8 0.0007
374 INTENTIONAL PRODUCT USE ISSUE 59 0.0007
375 MOBILITY DECREASED 48 0.0007
376 HEAD INJURY 21 0.0007
377 LIP SWELLING 22 0.0007
378 EMERGENCY CARE 2 0.0007
379 STOMATITIS 40 0.0007
380 DUODENITIS 2 0.0007
381 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 11 0.0006
382 THERAPEUTIC PRODUCT EFFECT DECREASED 29 0.0006
383 DEVICE OCCLUSION 9 0.0006
384 FOOT FRACTURE 12 0.0006
385 VIRAL UPPER RESPIRATORY TRACT INFECTION 3 0.0006
386 FURUNCLE 5 0.0006
387 ENDOMETRIOSIS 3 0.0006
388 GASTROOESOPHAGEAL REFLUX DISEASE 50 0.0006
389 ENTEROCOCCAL INFECTION 3 0.0006
390 POST PROCEDURAL INFECTION 5 0.0006
391 KIDNEY INFECTION 12 0.0006
392 HEPATOMEGALY 6 0.0006
393 NASOPHARYNGITIS 112 0.0006
394 LIGAMENT SPRAIN 6 0.0006
395 STAPHYLOCOCCAL INFECTION 20 0.0006
396 OTITIS MEDIA 2 0.0006
397 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 43 0.0006
398 INABILITY TO AFFORD MEDICATION 6 0.0006
399 EXPIRED DEVICE USED 2 0.0006
400 PEPTIC ULCER 2 0.0006
401 HEPATIC ENZYME ABNORMAL 3 0.0006
402 LYME DISEASE 2 0.0006
403 ABORTION SPONTANEOUS 24 0.0006
404 POST-TRAUMATIC STRESS DISORDER 4 0.0006
405 PRODUCT QUALITY ISSUE 81 0.0006
406 PRODUCT DOSE OMISSION ISSUE 175 0.0006
407 WEIGHT INCREASED 133 0.0006
408 COLITIS ISCHAEMIC 4 0.0006
409 HEPATIC CYST 2 0.0006
410 DIABETIC RETINOPATHY 2 0.0006
411 PANCREATITIS 31 0.0006
412 HYPERLIPIDAEMIA 7 0.0006
413 TOOTH DISORDER 13 0.0006
414 WRIST FRACTURE 7 0.0006
415 PRODUCT CONTAINER ISSUE 5 0.0006
416 RESPIRATORY TRACT INFECTION 15 0.0006
417 TONSILLITIS 3 0.0006
418 PRODUCT USE COMPLAINT 9 0.0006
419 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
420 URTICARIA 95 0.0006
421 MUSCLE SPASMS 104 0.0006
422 PRODUCT CONTAMINATION 2 0.0006
423 APPENDICECTOMY 2 0.0006
424 FRUSTRATION 2 0.0006
425 GASTROINTESTINAL DISORDER 50 0.0006
426 BRAIN OEDEMA 7 0.0006
427 GASTROENTERITIS VIRAL 10 0.0006
428 LIQUID PRODUCT PHYSICAL ISSUE 4 0.0005
429 NONSPECIFIC REACTION 3 0.0005
430 ANAPHYLACTIC REACTION 30 0.0005
431 NERVE COMPRESSION 5 0.0005
432 DISCOMFORT 33 0.0005
433 STREPTOCOCCAL INFECTION 3 0.0005
434 ANGIOPATHY 3 0.0005
435 SKIN INFECTION 6 0.0005
436 GENERAL SYMPTOM 4 0.0005
437 INCORRECT DRUG ADMINISTRATION DURATION 15 0.0005
438 LACERATION 5 0.0005
439 PROTEIN TOTAL DECREASED 2 0.0005
440 NO ADVERSE EVENT 96 0.0005
441 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
442 CHOLECYSTITIS ACUTE 3 0.0005
443 PARANASAL SINUS DISCOMFORT 2 0.0005
444 HOSPITALISATION 81 0.0005
445 FACE INJURY 2 0.0005
446 SCAR 9 0.0005
447 HIP ARTHROPLASTY 8 0.0005
448 MOUTH SWELLING 3 0.0005
449 DELIRIUM 18 0.0005
450 INFLUENZA 57 0.0005
451 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 28 0.0005
452 DRUG-INDUCED LIVER INJURY 16 0.0005
453 OESOPHAGEAL PAIN 2 0.0005
454 BACTERAEMIA 6 0.0005
455 ILLNESS 52 0.0005
456 BLADDER DISORDER 5 0.0005
457 APHONIA 7 0.0005
458 NEPHROLITHIASIS 23 0.0005
459 NECK PAIN 28 0.0005
460 MASS 7 0.0005
461 OBSTRUCTION 2 0.0005
462 CANDIDIASIS 2 0.0005
463 TYPE 1 DIABETES MELLITUS 3 0.0005
464 OEDEMA 27 0.0005
465 DRUG DOSE OMISSION 82 0.0005
466 FRUSTRATION TOLERANCE DECREASED 4 0.0005
467 ADRENAL INSUFFICIENCY 6 0.0005
468 SPINAL FUSION SURGERY 2 0.0005
469 BACK DISORDER 8 0.0005
470 BODY TEMPERATURE INCREASED 10 0.0005
471 GOITRE 2 0.0005
472 SELF-MEDICATION 2 0.0005
473 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 3 0.0005
474 ILEUS 6 0.0005
475 INFUSION SITE EXTRAVASATION 3 0.0005
476 FREQUENT BOWEL MOVEMENTS 13 0.0005
477 SUICIDAL BEHAVIOUR 2 0.0005
478 PULSELESS ELECTRICAL ACTIVITY 2 0.0005
479 CONTUSION 46 0.0005
480 OFF LABEL USE 413 0.0005
481 AORTIC VALVE INCOMPETENCE 2 0.0005
482 POST PROCEDURAL COMPLICATION 9 0.0005
483 ABDOMINAL PAIN 109 0.0005
484 DRY MOUTH 38 0.0005
485 EMOTIONAL DISTRESS 56 0.0005
486 THERAPEUTIC RESPONSE DECREASED 28 0.0005
487 DRUG SPECIFIC ANTIBODY PRESENT 3 0.0005
488 DEVICE ISSUE 41 0.0005
489 ASPIRATION 5 0.0005
490 INJURY 32 0.0005
491 DISABILITY 9 0.0005
492 ABDOMINAL ABSCESS 2 0.0005
493 DENTAL CARIES 5 0.0005
494 RHINITIS ALLERGIC 2 0.0004
495 RHEUMATOID ARTHRITIS 51 0.0004
496 INJECTION SITE URTICARIA 11 0.0004
497 SEPSIS 50 0.0004
498 IMPLANT SITE PAIN 2 0.0004
499 MENINGITIS ASEPTIC 2 0.0004
500 ADVERSE EVENT 41 0.0004
501 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
502 EYE INFECTION 5 0.0004
503 WEIGHT DECREASED 123 0.0004
504 ABNORMAL LOSS OF WEIGHT 3 0.0004
505 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
506 CYSTITIS 14 0.0004
507 INJECTION SITE PAPULE 2 0.0004
508 LYMPHOEDEMA 3 0.0004
509 BRONCHITIS 32 0.0004
510 HYPERTRANSAMINASAEMIA 3 0.0004
511 ARTHRITIS INFECTIVE 2 0.0004
512 SYNCOPE 43 0.0004
513 LIVER DISORDER 19 0.0004
514 FLANK PAIN 4 0.0004
515 ANAPHYLACTIC SHOCK 11 0.0004
516 PAPULE 3 0.0004
517 LEUKAEMIA 4 0.0004
518 HAND FRACTURE 3 0.0004
519 INFECTION 61 0.0004
520 HYPOAESTHESIA 63 0.0004
521 GESTATIONAL DIABETES 2 0.0004
522 JOINT STIFFNESS 11 0.0004
523 LIMB OPERATION 2 0.0004
524 CHEST PAIN 77 0.0004
525 MEMORY IMPAIRMENT 57 0.0004
526 LOCALISED INFECTION 10 0.0004
527 OSTEOPOROSIS 17 0.0004
528 CYST 5 0.0004
529 PROTEIN URINE PRESENT 2 0.0004
530 PHLEBITIS 2 0.0004
531 GENERAL PHYSICAL HEALTH DETERIORATION 45 0.0004
532 APHTHOUS ULCER 3 0.0004
533 HIATUS HERNIA 5 0.0004
534 PELVIC FRACTURE 3 0.0004
535 PERIORBITAL OEDEMA 2 0.0004
536 CONDITION AGGRAVATED 117 0.0004
537 ABDOMINAL PAIN UPPER 79 0.0004
538 BRAIN FOG 6 0.0004
539 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
540 COVID-19 67 0.0004
541 KNEE ARTHROPLASTY 8 0.0004
542 TOOTH INFECTION 5 0.0004
543 INCONTINENCE 4 0.0004
544 RENAL PAIN 4 0.0004
545 FOOD POISONING 2 0.0004
546 INTESTINAL RESECTION 2 0.0004
547 NEURALGIA 9 0.0004
548 SINUS CONGESTION 5 0.0004
549 CHEILITIS 2 0.0004
550 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
551 BLOOD POTASSIUM DECREASED 11 0.0004
552 ABDOMINAL DISCOMFORT 61 0.0004
553 AUTISM SPECTRUM DISORDER 2 0.0004
554 MENSTRUAL DISORDER 3 0.0004
555 HERNIA 7 0.0004
556 VIRAL INFECTION 12 0.0004
557 INTRACRANIAL PRESSURE INCREASED 2 0.0004
558 DRUG EFFECT INCOMPLETE 13 0.0004
559 UNEVALUABLE EVENT 27 0.0004
560 PRODUCT LEAKAGE 2 0.0004
561 SENSATION OF FOREIGN BODY 3 0.0004
562 THERAPY NON-RESPONDER 16 0.0004
563 HYPERTENSION 75 0.0004
564 HYPERSENSITIVITY 65 0.0003
565 COUGH 98 0.0003
566 JOINT SWELLING 42 0.0003
567 PARAESTHESIA ORAL 5 0.0003
568 HYPERVENTILATION 2 0.0003
569 LOSS OF CONSCIOUSNESS 44 0.0003
570 GASTRITIS 9 0.0003
571 MEDICATION ERROR 19 0.0003
572 COLD SWEAT 6 0.0003
573 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
574 PNEUMONIA 109 0.0003
575 SINUS HEADACHE 2 0.0003
576 OEDEMA PERIPHERAL 41 0.0003
577 GALLBLADDER DISORDER 6 0.0003
578 FACIAL PAIN 3 0.0003
579 IMMUNODEFICIENCY 5 0.0003
580 CONFUSIONAL STATE 54 0.0003
581 HEAVY MENSTRUAL BLEEDING 3 0.0003
582 INJECTION SITE VESICLES 2 0.0003
583 PRESYNCOPE 8 0.0003
584 UNDERDOSE 24 0.0003
585 JOINT INJURY 7 0.0003
586 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
587 PIGMENTATION DISORDER 2 0.0003
588 TOOTH EXTRACTION 4 0.0003
589 APPENDICITIS 3 0.0003
590 MALAISE 139 0.0003
591 MUSCULAR WEAKNESS 36 0.0003
592 PRODUCT PACKAGING ISSUE 3 0.0003
593 PULMONARY EMBOLISM 30 0.0003
594 PNEUMOTHORAX 5 0.0003
595 SCREAMING 2 0.0003
596 ACUTE RESPIRATORY FAILURE 6 0.0003
597 GLAUCOMA 6 0.0003
598 AMNESIA 20 0.0003
599 BODY TEMPERATURE DECREASED 3 0.0003
600 HEART RATE INCREASED 30 0.0003
601 BLOOD PRESSURE ABNORMAL 6 0.0003
602 CYTOMEGALOVIRUS INFECTION 5 0.0003
603 OVARIAN CYST 3 0.0003
604 VOMITING 141 0.0003
605 MENINGITIS 2 0.0003
606 SEIZURE 34 0.0003
607 INJECTION SITE RASH 9 0.0003
608 EAR DISCOMFORT 3 0.0003
609 INTESTINAL OBSTRUCTION 11 0.0003
610 COLITIS ULCERATIVE 13 0.0003
611 DRUG INTOLERANCE 28 0.0003
612 TREATMENT FAILURE 24 0.0003
613 VENTRICULAR EXTRASYSTOLES 3 0.0003
614 DIVERTICULITIS 8 0.0003
615 EXTRASYSTOLES 2 0.0003
616 SYRINGE ISSUE 5 0.0003
617 BURNING SENSATION 20 0.0003
618 DRUG INEFFECTIVE 372 0.0003
619 DIVERTICULUM 2 0.0003
620 DEPRESSION 64 0.0003
621 BODY HEIGHT DECREASED 3 0.0003
622 SKIN CANCER 6 0.0003
623 DEHYDRATION 37 0.0003
624 PANIC REACTION 2 0.0003
625 DYSPNOEA 156 0.0003
626 CRYING 10 0.0003
627 NEEDLE ISSUE 8 0.0003
628 GASTROENTERITIS 4 0.0003
629 ASTHENIA 103 0.0003
630 MAJOR DEPRESSION 2 0.0003
631 GASTROINTESTINAL PAIN 3 0.0003
632 EXTRA DOSE ADMINISTERED 11 0.0003
633 EXPIRED PRODUCT ADMINISTERED 9 0.0003
634 FUNGAL INFECTION 9 0.0003
635 NERVE INJURY 3 0.0003
636 FEELING DRUNK 2 0.0003
637 SUNBURN 2 0.0003
638 ANXIETY 76 0.0003
639 PAIN 164 0.0003
640 PARAESTHESIA 42 0.0003
641 FISTULA 3 0.0003
642 BLOOD CALCIUM DECREASED 3 0.0003
643 SCAB 3 0.0003
644 AORTIC ANEURYSM 2 0.0003
645 INTERNAL HAEMORRHAGE 3 0.0003
646 FEELING JITTERY 5 0.0003
647 BOWEL MOVEMENT IRREGULARITY 2 0.0003
648 FEELING HOT 16 0.0003
649 DRUG EFFECT DECREASED 14 0.0003
650 OROPHARYNGEAL PAIN 24 0.0003
651 THROAT TIGHTNESS 7 0.0003
652 ANKLE FRACTURE 4 0.0003
653 EYELID OEDEMA 3 0.0003
654 LUNG INFECTION 4 0.0003
655 CARDIAC DISORDER 24 0.0003
656 CHILLS 30 0.0003
657 HEADACHE 160 0.0003
658 CYANOSIS 4 0.0003
659 DYSPEPSIA 25 0.0003
660 MENTAL DISORDER 11 0.0003
661 PRODUCT PRESCRIBING ERROR 6 0.0003
662 FALL 83 0.0002
663 PYREXIA 86 0.0002
664 RHINITIS 2 0.0002
665 BLOOD POTASSIUM INCREASED 4 0.0002
666 URINARY TRACT INFECTION 42 0.0002
667 NO THERAPEUTIC RESPONSE 3 0.0002
668 ALOPECIA 48 0.0002
669 ESCHERICHIA INFECTION 2 0.0002
670 EYE SWELLING 9 0.0002
671 ACUTE CORONARY SYNDROME 2 0.0002
672 EMBOLISM 2 0.0002
673 HEMIPLEGIA 2 0.0002
674 COAGULOPATHY 4 0.0002
675 INJECTION SITE BRUISING 19 0.0002
676 THERAPY INTERRUPTED 17 0.0002
677 FACE OEDEMA 4 0.0002
678 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
679 PSEUDOMONAS INFECTION 2 0.0002
680 CARDIAC OPERATION 2 0.0002
681 POOR QUALITY SLEEP 5 0.0002
682 APHASIA 7 0.0002
683 BLOOD MAGNESIUM DECREASED 2 0.0002
684 MUSCLE STRAIN 2 0.0002
685 HYSTERECTOMY 2 0.0002
686 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
687 MUSCULOSKELETAL STIFFNESS 20 0.0002
688 ORAL CANDIDIASIS 3 0.0002
689 GROIN PAIN 2 0.0002
690 PULMONARY CONGESTION 3 0.0002
691 HERPES ZOSTER 13 0.0002
692 LIMB DISCOMFORT 7 0.0002
693 DIZZINESS 112 0.0002
694 SURGERY 13 0.0002
695 ARTHRALGIA 92 0.0002
696 TOOTHACHE 4 0.0002
697 GASTROINTESTINAL CARCINOMA 2 0.0002
698 IMPAIRED GASTRIC EMPTYING 3 0.0002
699 PANIC ATTACK 8 0.0002
700 DYSURIA 8 0.0002
701 PROCEDURAL PAIN 6 0.0002
702 FLUID RETENTION 11 0.0002
703 ARTHRITIS 17 0.0002
704 FEELING COLD 6 0.0002
705 PERSONALITY CHANGE 2 0.0002
706 INJECTION SITE PAIN 66 0.0002
707 CARPAL TUNNEL SYNDROME 3 0.0002
708 NEPHROPATHY 2 0.0002
709 PRODUCT USE IN UNAPPROVED INDICATION 53 0.0002
710 CHOLELITHIASIS 7 0.0002
711 SKIN REACTION 3 0.0002
712 ARTERIOSCLEROSIS 2 0.0002
713 PAIN IN JAW 6 0.0002
714 DECREASED APPETITE 49 0.0002
715 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
716 HYPERSOMNIA 6 0.0002
717 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
718 AFFECT LABILITY 2 0.0002
719 ATELECTASIS 2 0.0002
720 INFLUENZA LIKE ILLNESS 17 0.0002
721 ORAL HERPES 4 0.0002
722 INFLAMMATORY BOWEL DISEASE 2 0.0002
723 LABORATORY TEST ABNORMAL 6 0.0002
724 CATARACT 12 0.0002
725 NAUSEA 158 0.0002
726 BRAIN INJURY 2 0.0002
727 CELLULITIS 10 0.0002
728 HYPOTHERMIA 2 0.0002
729 FEEDING DISORDER 4 0.0002
730 VERTIGO 12 0.0002
731 BLOOD PRESSURE DECREASED 13 0.0002
732 DRUG ADMINISTRATION ERROR 6 0.0002
733 THERAPY CESSATION 10 0.0002
734 NEOPLASM MALIGNANT 13 0.0002
735 LYMPHOMA 3 0.0002
736 INJECTION SITE PRURITUS 13 0.0002
737 PAIN IN EXTREMITY 57 0.0002
738 HAEMATOMA 5 0.0002
739 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
740 BASAL CELL CARCINOMA 3 0.0002
741 ACCIDENTAL OVERDOSE 7 0.0002
742 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
743 BLOOD PRESSURE INCREASED 29 0.0002
744 INJECTION SITE MASS 7 0.0002
745 SUDDEN DEATH 2 0.0002
746 INJECTION SITE REACTION 13 0.0002
747 BRADYCARDIA 10 0.0002
748 RASH 82 0.0002
749 EATING DISORDER 4 0.0002
750 PALPITATIONS 22 0.0002
751 DECREASED ACTIVITY 2 0.0002
752 DEEP VEIN THROMBOSIS 12 0.0002
753 FAECES DISCOLOURED 4 0.0002
754 PRODUCT PRESCRIBING ISSUE 4 0.0002
755 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
756 OESOPHAGITIS 2 0.0002
757 BLOOD GLUCOSE FLUCTUATION 2 0.0002
758 PHOTOSENSITIVITY REACTION 3 0.0002
759 RESPIRATORY DISTRESS 5 0.0002
760 INSOMNIA 48 0.0002
761 HYPERTENSIVE CRISIS 2 0.0002
762 DYSPHAGIA 17 0.0002
763 SNEEZING 4 0.0002
764 THROAT IRRITATION 8 0.0002
765 OXYGEN SATURATION DECREASED 10 0.0002
766 GAIT DISTURBANCE 34 0.0002
767 HEMIPARESIS 3 0.0002
768 REBOUND EFFECT 2 0.0002
769 IMPAIRED DRIVING ABILITY 2 0.0002
770 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
771 CHOLECYSTECTOMY 2 0.0002
772 CONVULSION 10 0.0002
773 GASTRIC DISORDER 6 0.0002
774 FATIGUE 136 0.0002
775 PERICARDIAL EFFUSION 4 0.0002
776 FOETAL EXPOSURE DURING PREGNANCY 14 0.0002
777 HAEMORRHAGE 18 0.0002
778 LIVER FUNCTION TEST ABNORMAL 5 0.0002
779 POST PROCEDURAL HAEMORRHAGE 2 0.0002
780 CAESAREAN SECTION 2 0.0002
781 HEART RATE DECREASED 6 0.0002
782 HEAD DISCOMFORT 3 0.0002
783 ACCIDENT 2 0.0002
784 GOUT 3 0.0002
785 OSTEOMYELITIS 3 0.0002
786 LACRIMATION INCREASED 5 0.0002
787 DIARRHOEA 106 0.0002
788 RECTAL HAEMORRHAGE 7 0.0002
789 FEELING ABNORMAL 39 0.0002
790 ABNORMAL WEIGHT GAIN 2 0.0002
791 INJECTION SITE ERYTHEMA 20 0.0002
792 THINKING ABNORMAL 3 0.0002
793 INJECTION SITE DISCOLOURATION 2 0.0002
794 AGGRESSION 8 0.0002
795 SECRETION DISCHARGE 2 0.0002
796 DYSARTHRIA 6 0.0002
797 BACK PAIN 37 0.0002
798 POISONING 2 0.0002
799 BLOOD SODIUM DECREASED 3 0.0002
800 ABDOMINAL PAIN LOWER 4 0.0002
801 INJECTION SITE IRRITATION 2 0.0002
802 HEPATITIS 4 0.0002
803 RASH GENERALISED 4 0.0002
804 SKIN IRRITATION 7 0.0002
805 INCORRECT PRODUCT STORAGE 2 0.0002
806 BEDRIDDEN 2 0.0002
807 IMMUNE SYSTEM DISORDER 2 0.0002
808 HYPOKALAEMIA 7 0.0002
809 SARS-COV-2 TEST POSITIVE 2 0.0002
810 DEPRESSED MOOD 8 0.0002
811 DYSMENORRHOEA 2 0.0002
812 EYE HAEMORRHAGE 2 0.0001
813 URINARY RETENTION 5 0.0001
814 PRODUCT ADMINISTRATION ERROR 3 0.0001
815 RASH PRURITIC 8 0.0001
816 BLINDNESS 6 0.0001
817 MYALGIA 25 0.0001
818 PALLOR 4 0.0001
819 PRODUCTIVE COUGH 7 0.0001
820 TACHYCARDIA 13 0.0001
821 TREMOR 24 0.0001
822 MOUTH ULCERATION 3 0.0001
823 HYPOXIA 5 0.0001
824 CEREBROVASCULAR ACCIDENT 24 0.0001
825 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
826 PARALYSIS 2 0.0001
827 HYPOTENSION 28 0.0001
828 IMPAIRED QUALITY OF LIFE 2 0.0001
829 PRURITUS GENERALISED 3 0.0001
830 VAGINAL HAEMORRHAGE 6 0.0001
831 ANOSMIA 2 0.0001
832 DEVICE DISLOCATION 6 0.0001
833 APPLICATION SITE PAIN 3 0.0001
834 NERVOUSNESS 7 0.0001
835 PANCREATITIS ACUTE 3 0.0001
836 HEART RATE IRREGULAR 3 0.0001
837 HYPOAESTHESIA ORAL 2 0.0001
838 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
839 DEVICE FAILURE 2 0.0001
840 MUSCULOSKELETAL CHEST PAIN 2 0.0001
841 RENAL DISORDER 6 0.0001
842 HAEMATOCHEZIA 7 0.0001
843 DISORIENTATION 5 0.0001
844 ABSCESS 2 0.0001
845 BLOOD PRESSURE FLUCTUATION 3 0.0001
846 SENSORY DISTURBANCE 2 0.0001
847 EYE PAIN 7 0.0001
848 RHINORRHOEA 8 0.0001
849 PRURITUS 47 0.0001
850 EYE DISORDER 4 0.0001
851 ERYTHEMA 25 0.0001
852 VISUAL IMPAIRMENT 15 0.0001
853 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
854 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
855 PNEUMONIA ASPIRATION 3 0.0001
856 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
857 NASAL CONGESTION 7 0.0001
858 EYE PRURITUS 4 0.0001
859 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
860 BREAST CANCER 11 0.0001
861 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
862 INJECTION SITE SWELLING 9 0.0001
863 HYPERHIDROSIS 15 0.0001
864 UNRESPONSIVE TO STIMULI 3 0.0001
865 MUSCULOSKELETAL DISCOMFORT 2 0.0001
866 DEVICE DEFECTIVE 2 0.0001
867 PRODUCT STORAGE ERROR 10 0.0001
868 AMENORRHOEA 2 0.0001
869 LYMPHADENOPATHY 4 0.0001
870 PULMONARY OEDEMA 5 0.0001
871 JAUNDICE 3 0.0001
872 RESTLESS LEGS SYNDROME 2 0.0001
873 RESTLESSNESS 4 0.0001
874 AGITATION 8 0.0001
875 RESPIRATORY ARREST 3 0.0001
876 SKIN DISCOLOURATION 5 0.0001
877 CONJUNCTIVITIS 2 0.0001
878 EPISTAXIS 8 0.0001
879 COMA 5 0.0001
880 SLEEP APNOEA SYNDROME 2 0.0001
881 LETHARGY 6 0.0001
882 DRUG PRESCRIBING ERROR 2 0.0001
883 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
884 HAEMORRHOIDS 2 0.0001
885 CHOKING 2 0.0001
886 MENORRHAGIA 2 0.0001
887 URINARY INCONTINENCE 3 0.0001
888 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
889 SPINAL FRACTURE 2 0.0001
890 HEPATIC FAILURE 3 0.0001
891 CORONARY ARTERY DISEASE 3 0.0001
892 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20 0.0001
893 RENAL FAILURE 13 0.0001
894 PRODUCT PREPARATION ERROR 2 0.0001
895 RIB FRACTURE 2 0.0001
896 INCORRECT DOSE ADMINISTERED 22 0.0001
897 NERVOUS SYSTEM DISORDER 3 0.0001
898 SPEECH DISORDER 5 0.0001
899 MOOD SWINGS 3 0.0001
900 RETCHING 2 0.0001
901 IMPAIRED WORK ABILITY 2 0.0001
902 MOVEMENT DISORDER 3 0.0001
903 HYPOACUSIS 4 0.0001
904 HOT FLUSH 7 0.0001
905 MELAENA 2 0.0001
906 SOMNOLENCE 18 0.0001
907 RASH MACULAR 3 0.0001
908 CARDIAC ARREST 7 0.0001
909 DEATH 73 0.0001
910 ANAEMIA 16 0.0001
911 RASH ERYTHEMATOUS 4 0.0001
912 IRRITABILITY 5 0.0001
913 MENTAL IMPAIRMENT 2 0.0001
914 HYPOGLYCAEMIA 4 0.0001
915 BALANCE DISORDER 7 0.0001
916 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
917 AGEUSIA 2 0.0001
918 VISION BLURRED 11 0.0001
919 COLITIS 3 0.0001
920 GASTRIC CANCER 2 0.0001
921 HAEMATEMESIS 2 0.0001
922 HYPOPHAGIA 2 0.0001
923 DEAFNESS 2 0.0001
924 CARDIAC FAILURE CONGESTIVE 6 0.0001
925 MENSTRUATION IRREGULAR 2 0.0001
926 MYOCARDIAL INFARCTION 13 0.0001
927 FEAR 2 0.0001
928 DISTURBANCE IN ATTENTION 4 0.0001
929 LUNG NEOPLASM MALIGNANT 3 0.0001
930 MENTAL STATUS CHANGES 2 0.0001
931 ATRIAL FIBRILLATION 7 0.0001
932 CARDIO-RESPIRATORY ARREST 3 0.0001
933 HAEMOPTYSIS 2 0.0001
934 DEMENTIA 2 0.0001
935 DEVICE MALFUNCTION 5 0.0001
936 RENAL FAILURE ACUTE 3 0.0001
937 FLATULENCE 4 0.0001
938 RED BLOOD CELL COUNT DECREASED 2 0.0001
939 ANGINA PECTORIS 2 0.0001
940 OVERDOSE 15 0.0001
941 PSORIASIS 9 0.0001
942 RESPIRATORY FAILURE 5 0.0001
943 ASCITES 2 0.0001
944 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
945 PREMATURE BABY 2 0.0001
946 DIABETES MELLITUS 5 0.0001
947 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
948 EMOTIONAL DISORDER 2 0.0001
949 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
950 DISEASE RECURRENCE 3 0.0001
951 INJECTION SITE HAEMORRHAGE 5 0.0001
952 INTENTIONAL OVERDOSE 4 0.0001
953 HIP FRACTURE 2 0.0001
954 PRODUCT DOSE OMISSION 4 0.0001
955 OSTEONECROSIS 2 0.0001
956 LEUKOPENIA 3 0.0001
957 CONSTIPATION 13 0.0001
958 FLUSHING 6 0.0001
959 HAEMATURIA 2 0.0001
960 NEOPLASM PROGRESSION 2 0.0001
961 HYPERGLYCAEMIA 2 0.0001
962 DYSGEUSIA 4 0.0001
963 DYSPNOEA EXERTIONAL 2 0.0001
964 BLOOD GLUCOSE INCREASED 10 0.0001
965 BONE PAIN 3 0.0001
966 HAEMOGLOBIN DECREASED 5 0.0000
967 POLLAKIURIA 2 0.0000
968 SEPTIC SHOCK 2 0.0000
969 BLOOD CREATININE INCREASED 3 0.0000
970 INTENTIONAL PRODUCT MISUSE 4 0.0000
971 ARRHYTHMIA 2 0.0000
972 OCULAR HYPERAEMIA 2 0.0000
973 RENAL CANCER 2 0.0000
974 MULTIPLE SCLEROSIS 2 0.0000
975 ACNE 3 0.0000
976 PLATELET COUNT DECREASED 4 0.0000
977 CARDIAC FAILURE 3 0.0000
978 DRUG DEPENDENCE 6 0.0000
979 DEPENDENCE 2 0.0000
980 COMPLETED SUICIDE 3 0.0000
981 SUICIDE ATTEMPT 2 0.0000
982 DRUG INTERACTION 5 0.0000
983 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
984 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
985 THROMBOCYTOPENIA 3 0.0000
986 RENAL IMPAIRMENT 2 0.0000
987 SUICIDAL IDEATION 2 0.0000
988 NEUROPATHY PERIPHERAL 2 0.0000
989 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
990 TOXICITY TO VARIOUS AGENTS 3 0.0000
991 DISEASE PROGRESSION 2 0.0000